Comment on "Locoregional Failure During and After Short-Course Radiotherapy Followed by Chemotherapy and Surgery Compared to Long-Course Chemoradiotherapy and Surgery: A Five-Year Follow-Up of the RAPIDO Trial": The RAPIDO Trial Does Not Achieve Its Primary Endpoint
Ann Surg Open. 2023 Jun 2;4(2):e288.
doi: 10.1097/AS9.0000000000000288.
eCollection 2023 Jun.
1 From the University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier Cancer Institute (ICM), Univ Montpellier, INSERM U1194 IRCM, Montpellier, France.
2 Biometrics Unit ICM, Montpellier Cancer Institute, Univ Montpellier, Montpellier, France.
3 Institut de Cancérologie de Lorraine, APEMAC, Université de Lorraine, Nancy, France.